Filters
reset allOther countries
Results: 1 to 6 of 6
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States | 345 | 159 |
|
Cerebral Cavernous Malformations Panel PreventionGenetics United States | 3 | 3 |
|
Cerebral Cavernous Malformations via the KRIT1/CCM1 Gene PreventionGenetics United States | 1 | 1 |
|
Cerebral Cavernous Malformations via the KRIT1/CCM1 Gene, Exon 10 PreventionGenetics United States | 1 | 1 |
|
Cerebral cavernous familial: KRIT1 gene mutation analysis (c.1363C>T, dG699, Q698X) GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Spain | 1 | 1 |
|
Results: 1 to 6 of 6
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.